Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Myeloid 2CNS 1

Conditions

Leukemia, Myeloid, Acute 19Myelodysplastic Syndromes 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Myeloproliferative Disorders 14Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Mantle-Cell 11Leukemia, Myelomonocytic, Chronic 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Hodgkin Disease 11Lymphoma, Non-Hodgkin 10Multiple Myeloma 9Leukemia, Myeloid, Chronic-Phase 9Lymphoma, Large B-Cell, Diffuse 8Waldenstrom Macroglobulinemia 7Myelodysplastic-Myeloproliferative Diseases 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7Primary Myelofibrosis 6Leukemia, Prolymphocytic 6Leukemia, Biphenotypic, Acute 6Lymphoma 5Leukemia 5Burkitt Lymphoma 5Blast Crisis 5Anemia, Refractory, with Excess of Blasts 5Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Graft vs Host Disease 4Congenital Abnormalities 4Pdgfra-Associated Chronic Eosinophilic Leukemia 3Lymphoma, Large-Cell, Immunoblastic 3

Interventions

fludarabine phosphate 34Cyclophosphamide 31Peripheral Blood Stem Cell Transplantation 27Mycophenolic Acid 25Cyclosporine 23Antilymphocyte Serum 23Busulfan 20Tacrolimus 17Radiotherapy 17Filgrastim 17Whole-Body Irradiation 15Methotrexate 15Methylprednisolone 14Melphalan 13Cord Blood Stem Cell Transplantation 12venetoclax 9Cytarabine 8Azacitidine 8fludarabine 5Etoposide 5sargramostim 4Therapeutics 4Sirolimus 4Decitabine 4Clofarabine 4Alemtuzumab 4thymoglobulin 3nilotinib 3merphos 2Voriconazole 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recurrence × Cyclosporins × Myeloid × Clear all
NCT00036738 2020-01-29

Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib

Fred Hutchinson Cancer Center

Phase 2 Completed
28 enrolled 10 charts
LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Recurrence, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00003145 2020-01-10

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia

Fred Hutchinson Cancer Center

Phase 2 Completed
18 enrolled
MyeloidOther hematologic neoplasm

Recurrence, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡